IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
申请人:UCB Biopharma SRL
公开号:EP3080111B1
公开(公告)日:2020-05-27
Imidazopyridine Derivatives As Modulators of TNF Activity
申请人:UCB BIOPHARMA SPRL
公开号:US20160304511A1
公开(公告)日:2016-10-20
A series of substituted 1H imidazo[4,5-b]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.